Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial

Animal models of serious infection suggest that 24 h of induced hypothermia improves circulatory and respiratory function and reduces mortality. We tested the hypothesis that a reduction of core temperature to 32–34°C attenuates organ dysfunction and reduces mortality in ventilator-dependent patients with septic shock.